http://www.zibb.com/healthcare/theme/cq/AstraZeneca+Plc Zibb. The Global business search engine. en-US search@zibb.com (RB Search)Copyright (c) 2007 Reed Business Information. All rights reserved.Sat, 21 Nov 2009 00:46:00 GMTSat, 21 Nov 2009 00:46:00 GMT608831http://www.zibb.com/healthcare/theme/cq/AstraZeneca+Plc http://www.zibb.com/images/en/g_zibb_logo_beta.gif http://finance.yahoo.com/news/US-Court-of-Appeals-Upholds-prnews-464568436.html?x=0&.v=1BOSTON, Nov. 20 /PRNewswire/ -- The United States Court of Appeals for the First Circuit upheld an earlier District Court ruling yesterday, approving a settlementhttp://finance.yahoo.com/news/US-Court-of-Appeals-Upholds-prnews-464568436.html?x=0&.v=1AstraZeneca PlcSat, 21 Nov 2009 00:46:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=11149AstraZeneca today announced it has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for ticagrelor, an investigational oral antiplatelet treatment for the reduction of major adverse cardiac events in patients with ahttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=11149AstraZeneca PlcFri, 20 Nov 2009 01:00:00 GMThttp://www.minyanville.com/articles/drug-cardiac-blood-thinner-plavix-brilinta-effient-minyanville/index/a/25552/from/yahooThe pharmaceutical landscape is rapidly changing as patents for some of the blockbuster drugs of the last decade near expiration and other players try to grab some of the remaining revenues before gehttp://www.minyanville.com/articles/drug-cardiac-blood-thinner-plavix-brilinta-effient-minyanville/index/a/25552/from/yahooAstraZeneca PlcThu, 19 Nov 2009 20:10:00 GMThttp://www.biospace.com/news_story.aspx?StoryID=163389&full=1This submission is based on the results of a comprehensive program, including data from PLATO (A Study of Platelet Inhibition and Patient Outcomes), the Phase III head-to-head trial comparing ticagrelor plus aspirin with clopidogrel (Plavix®) plus aspirin.http://www.biospace.com/news_story.aspx?StoryID=163389&full=1AstraZeneca PlcThu, 19 Nov 2009 12:00:00 GMThttp://www.foxbusiness.com/story/markets/industries/health-care/astrazeneca-submits-brilinta-nda-fda/?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+foxbusiness%2Fhealthcare+%28FOXBusiness.com+-+Industries+-+Health+Care%29AstraZeneca Submits Brilinta NDA To FDAhttp://www.foxbusiness.com/story/markets/industries/health-care/astrazeneca-submits-brilinta-nda-fda/?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+foxbusiness%2Fhealthcare+%28FOXBusiness.com+-+Industries+-+Health+Care%29AstraZeneca PlcThu, 19 Nov 2009 07:28:00 GMThttp://multivu.prnewswire.com/mnr/astrazeneca/41189/ORLANDO, Fla., Nov. 17 /PRNewswire/ -- A new analysis of 6,801 women in the JUPITER study showed CRESTOR (rosuvastatin calcium) 20 mg significantly reduced cardiovascular (CV) events (defined as the combined risk of myocardial infarction, stroke, arterial revascularization, hospitalizationhttp://multivu.prnewswire.com/mnr/astrazeneca/41189/AstraZeneca PlcTue, 17 Nov 2009 21:00:00 GMThttp://seekingalpha.com/article/173653-palatin-technologies-f1q10-qtr-end-9-30-09-earnings-call-transcript?source=yahooBefore we begin our remarks, I would like to remind you that statements made by Palatin that are not historical facts may be forward-looking statements.http://seekingalpha.com/article/173653-palatin-technologies-f1q10-qtr-end-9-30-09-earnings-call-transcript?source=yahooAstraZeneca PlcMon, 16 Nov 2009 20:50:22 GMThttp://www.marketwatch.com/story/astrazeneca-lifted-to-buy-roche-cut-to-hold-rbs-2009-11-09?siteid=yhoof2MADRID (MarketWatch) -- U.K. pharmaceutical group AstraZeneca was upgraded to buy from hold on Monday at Royal Bank of Scotland, which cited potential for strong cash flow generation. The investment bank said while there is litigation risk to AstraZeneca related to marketing over its schizophrenichttp://www.marketwatch.com/story/astrazeneca-lifted-to-buy-roche-cut-to-hold-rbs-2009-11-09?siteid=yhoof2AstraZeneca PlcMon, 09 Nov 2009 08:53:40 GMThttp://triangle.bizjournals.com/triangle/stories/2009/11/02/daily9.html?ana=yfcpcAstraZeneca (NYSE: AZN) says the arrangement will speed up the process for getting drugs to market by using the Durham-based clinical research organization’s global network.http://triangle.bizjournals.com/triangle/stories/2009/11/02/daily9.html?ana=yfcpcAstraZeneca PlcMon, 02 Nov 2009 17:05:24 GMThttp://www.hemscott.com/news/comment-archive/item.do?id=79209MORNINGSTAR VIEW: Astra's results were strong but we believe this was driven by a number of unsustainable factorsDamien Conover reports...http://www.hemscott.com/news/comment-archive/item.do?id=79209AstraZeneca PlcThu, 29 Oct 2009 16:55:45 GMThttp://www.forbes.com/2009/10/28/zactima-cancer-astrazeneca-business-healthcare-astrazeneca.html?feed=rss_business_healthcareIn a big setback for AstraZeneca, the British drugmaker withdrew its application for approval of its experimental lung cancer drug Zactima after new data from big trials showed that the drug did not extend the lives of lung cancer patients.http://www.forbes.com/2009/10/28/zactima-cancer-astrazeneca-business-healthcare-astrazeneca.html?feed=rss_business_healthcareAstraZeneca PlcWed, 28 Oct 2009 18:23:10 GMThttp://www.ft.com/cms/s/dc30445c-c197-11de-b86b-00144feab49a,Authorised=false.html?_i_location=http%3A%2F%2Fwww.ft.com%2Fcms%2Fs%2F0%2Fdc30445c-c197-11de-b86b-00144feab49a.html%3Fftcamp%3Drss%26nclick_check%3D1&_i_referer=&ftcamp=rss&nclick_check=1AstraZeneca, the Anglo-Swedish pharmaceutical group, is paying car assembly plant experts to help improve manufacturing efficiency in its factories, in an unusual job-lending programme triggered by the downturn.http://www.ft.com/cms/s/dc30445c-c197-11de-b86b-00144feab49a,Authorised=false.html?_i_location=http%3A%2F%2Fwww.ft.com%2Fcms%2Fs%2F0%2Fdc30445c-c197-11de-b86b-00144feab49a.html%3Fftcamp%3Drss%26nclick_check%3D1&_i_referer=&ftcamp=rss&nclick_check=1AstraZeneca PlcSun, 25 Oct 2009 19:52:45 GMThttp://www.pharmaasia.com/article-8045-astrazenecaasthmatreatmentgetsapprovalinjapan-asia.htmlThe product will be manufactured and developed by AstraZeneca and distributed and sold by Astellas Pharma, while promotion will be jointly carried out by both companies.http://www.pharmaasia.com/article-8045-astrazenecaasthmatreatmentgetsapprovalinjapan-asia.htmlAstraZeneca PlcThu, 22 Oct 2009 00:00:00 GMThttp://www.pharmamanufacturing.com/industrynews/2009/177.html?CMP=ILC-rssA Kentucky jury has hit British drugmaker AstraZeneca PLC with a $14.7 million verdict in a case that claimed the company inflated its prescription drug prices for Medicaid reimbursements.http://www.pharmamanufacturing.com/industrynews/2009/177.html?CMP=ILC-rssAstraZeneca PlcFri, 16 Oct 2009 07:00:59 GMThttp://www.genengnews.com/news/bnitem.aspx?name=64089908Original agreement to discover, develop, and commercialize compounds that target melanocortin receptors and work against obesity and related indications was inked in January 2007.http://www.genengnews.com/news/bnitem.aspx?name=64089908AstraZeneca PlcTue, 29 Sep 2009 00:00:00 GMThttp://www.pharmaceutical-business-review.com/news/sanofi_receives_additional_order_for_h1n1_vaccine_from_us_government_090922New order is for the production of bulk antigen equivalent to 27.3 million doses based on 15mcg of antigen per dosehttp://www.pharmaceutical-business-review.com/news/sanofi_receives_additional_order_for_h1n1_vaccine_from_us_government_090922AstraZeneca PlcTue, 22 Sep 2009 00:00:00 GMThttp://news.prnewswire.com/ViewContent.aspx?ACCT=109&STORY=/www/story/09-17-2009/0005096390&EDATE=WILMINGTON, Del., Sept. 17 /PRNewswire-FirstCall/ -- AstraZeneca (NYSE: AZN) accepted the 2009 Secretary of Defense Employer Support Freedom Award on Thursday at a ceremony in Washington, D.C. This award is the highest recognition given by the U.S.http://news.prnewswire.com/ViewContent.aspx?ACCT=109&STORY=/www/story/09-17-2009/0005096390&EDATE=AstraZeneca PlcThu, 17 Sep 2009 23:30:00 GMThttp://www.pharmalive.com/News/index.cfm?articleid=651858NEW HAVEN, Conn., Sept. 16 /PRNewswire/ -- Rib-X Pharmaceuticals, Inc., a company focused on the discovery, development and commercialization of novel drugs for the treatment of multi-antibiotic resistant infections, today announced that Tony Zook has been appointed to the Company's Board ofhttp://www.pharmalive.com/News/index.cfm?articleid=651858AstraZeneca PlcTue, 15 Sep 2009 22:00:00 GMThttp://www.guardian.co.uk/business/marketforceslive/2009/sep/01/shire-astrazenecaShire and AstraZeneca report positive clinical trial results, but SkyePharma's asthma drug has hit problemshttp://www.guardian.co.uk/business/marketforceslive/2009/sep/01/shire-astrazenecaAstraZeneca PlcTue, 01 Sep 2009 07:14:41 GMThttp://www.medicalfacts.nl/2009/08/13/astrazeneca-interessante-werkgever/Weinig last van de recessie AstraZeneca heeft de afgelopen maanden weinig last gehad van de recessie. De farmaceut profiteerde van het feit dat er op de markthttp://www.medicalfacts.nl/2009/08/13/astrazeneca-interessante-werkgever/AstraZeneca PlcThu, 13 Aug 2009 08:15:12 GMThttp://money.cnn.com/2009/08/05/news/companies/top_generic_drugs.fortune/index.htm?source=yahoo_quoteBehind every new branded drug is a generic copycat ready to start selling a nearly exact yet much cheaper version virtually the day patent protection ends.http://money.cnn.com/2009/08/05/news/companies/top_generic_drugs.fortune/index.htm?source=yahoo_quoteAstraZeneca PlcWed, 05 Aug 2009 16:28:00 GMThttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3007448&HITNO=10&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=biotechnology%20pharmaceutical&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R%3adate&R=3007448&THISHREF=http%3a//c.moreover.com/click/here.pl%3fz2084507477%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBiotechnology and Pharmaceutical Industry Search Find Companies, News, Events, Jobs, Directoryhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3007448&HITNO=10&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=biotechnology%20pharmaceutical&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R%3adate&R=3007448&THISHREF=http%3a//c.moreover.com/click/here.pl%3fz2084507477%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comAstraZeneca PlcTue, 14 Jul 2009 04:12:20 GMThttp://www.bizjournals.com/triad/stories/2009/07/13/story4.html?ana=from_rssThe decision this week by pharmaceutical giant AstraZeneca to keep pushing ahead with a drug targeting attention deficit/hyperactivity disorder, or ADHD, gives its Triad-based biotech partner Targacept a welcome jolt of good news.http://www.bizjournals.com/triad/stories/2009/07/13/story4.html?ana=from_rssAstraZeneca PlcMon, 13 Jul 2009 04:00:00 GMThttp://www.contractpharma.com/news/2009/07/08/astrazeneca_to_advance_nnr_therapeuticsAstraZeneca plans to further develop AZD3480 (TC-1734) for attention deficit/hyperactivity disorder (ADHD) and will make a $10 million milestone payment to Targacept.http://www.contractpharma.com/news/2009/07/08/astrazeneca_to_advance_nnr_therapeuticsAstraZeneca PlcWed, 08 Jul 2009 13:51:00 GMThttp://blogs.wsj.com/health/2009/06/10/astrazeneca-chalks-up-seroquel-dismissal-in-state-court/#mod=yahoo_hsThe judge said in his opinion that he was unconvinced by one of the plaintiff's expert witnesses.http://blogs.wsj.com/health/2009/06/10/astrazeneca-chalks-up-seroquel-dismissal-in-state-court/#mod=yahoo_hsAstraZeneca PlcWed, 10 Jun 2009 20:08:48 GMT